| Tag | Content |
|---|
EnhancerAtlas ID | HS073-14044 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr8:103900530-103902580 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr5a2 | MA0505.1 | chr8:103901771-103901786 | AAATTCAAGGCCAGG | + | 6.7 | | Zfx | MA0146.2 | chr8:103901219-103901233 | GAGGCCGAGGCGGG | - | 6.01 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_66635 | chr8:103902016-103902716 | Jurkat |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH08I102889 | chr8 | 103902017 | 103902716 |
|
Enhancer Sequence | TTGAACTCCT GACCACAGGT GATCCGCCTG CCTCAGTCTC CCGAAGTCCT GGGATTACAG 60
ACATGAGCCA CTCCACCCAG CCTTCCGAGC ACTATATTAG GCGCTGGGGA TACTTAGAAG 120
AGTGAATGCC CTTTCGGACA TGGGTTCCAA TCTGGCTTAA CCACTATCTT TCTGGGTAAC 180
TTTGAGCATG CTTCTTAAGC TTTCTGAGCC TGAGTTTATT CAACTGTTAA ATATGTACAA 240
TAATTTCTAT GTCATAAGAT TGTTGATAGG ACTGGAAACA CATGCAAAGG GCTTAGCCCA 300
GCTCAGTGTT CATACAAGGA GAAGCTCCTC AGCCAGGCCT GCTGGCTCAC GTCTGTAATC 360
CCAACACTTT GGGAGGCTGA GGCAGGTGAA TCAATTGAAC TCGAGAGTTC GAGACCAACC 420
TGGGTAACAT GGCAAAACCC TATCTCTACA AAAAATACAA AAATTAGCTG GGTGTGGTAG 480
TGCCTGCCTA TAGTCCCAGC TACTCAGGAG GGGGAGGCTA AGGTGGGAGG ATTTCTTGAG 540
CCTCCGAGGT GGAGGTTGCA GTGAGCCAAG ATTGTGCCAC TGCACTCCAG CCTAGGCAAC 600
AGAATGAGCC CCTGTCTCAA AAAAAAAAAA AAAAAAAAAA AAATTCAAGC CGGGTGCGGT 660
GGTTCATGCC TGTAATTCCA GCACTTTGGG AGGCCGAGGC GGGCGGATCA GGAGGTCAGG 720
AGATCGAGAC CATCCTGGCT AACACGGTGA AACCCCGTCT CTACTAAAAA TACAAAAAAT 780
TAACCGGGCA TGGTGGTGGG CGCCTGTAGT CCCAACTGCT GGGGAGGCTG AGGCAGAAGA 840
ATGGCATGAA CCTGGGAGGT GGAGCTTGCA GTGAGTCGAG ATCGCATCAC TGCACTCCAG 900
TCTGGGCAAC AGAGCAAGAC TCCGTCTCAA AAAAAAAAAT TATTTACTAT AGAACTTGTA 960
TATGTATTCT TGAAAAAGAA TTCAAAGGGA GAACCTCTTC CCAGGGTCAC AGAGTGATCA 1020
GTGCCACAGC TTGGACTTGG AGCCTTAGCT TATCTGCCAT CTTCCTACTG CATCAAAGCA 1080
GAGATTGCCA CGTGATTGCC CAGTGTGATT GAAAGTTTGA AGTCCGTATT TCTCTGAAAA 1140
CTTTGGTGTA TCTAGATTCT GTATGTCTCT TGGACAGATG AAGAGCTGCT GTACACAGAA 1200
GGGAGATTTT TTTTTTTAAT TGAGGAATCT AACTCAAGAA TAAATTCAAG GCCAGGTGCA 1260
GTGGCTCACG CCTGTAATCC CAGCACTTTG GGAGGCCGGG GTGGAAGGAT CACCTGAGGT 1320
CAGTAGTTCG AGACCAGCCT GACCAACGTG GTGAAACCCT GTCTCTACTA AAAATACAAA 1380
AATGAGCTGG GGGTGGTGGC GTGTGCCTGT AGTTCCAGCT ACTCAGGAGA CTGAGGCACA 1440
GGAATCACTT GAACCTGGGA GGTGGAGATT GCAGTGAGTT GAGATCATAC CACTGCACTC 1500
CAGCCTGGGT AACAGAGCAA GACTCCATCT CAAAAAAAAA GGAAAAGAAA TTTGGATCCT 1560
TTAGAAATCT TCAGACACTT GGCATAACAT GAAGTTAAAA CAACACCCCA CTTAGTTCCA 1620
TGATATTTCT GATGAATAAG AAATATGACA CCACAGAGTG AAACCAATAT TTTTAAAAAC 1680
CTCCTGAAGA GACTTTTTTT CTTTGTTGAT TACCATCCAG AGACAACATT TGTTTGAAAC 1740
TTTGAACAGA ATCAGTTTGT AGGGATGAAA CCCTCATTCT TCCCCGCCTG GGCCCAGACT 1800
TTCCATATCT TGTACTCTGA GAACCTTAAA GTCTTGAAAT GATTTGCAGT CCCAGCGAAG 1860
AAGCTAAAAT CAAAACTGAT TTGGGGAAAA ACCGTTTACT TTCTGACCTC TTTGTACTCT 1920
TCAGAGAATT TTTGTATGCT TGTTTATTTT CTTAATGTCT CTTGGTAATG TTTTTTCCTG 1980
TTTTGGTTTC ATATATGAAA TGTTCCATCT GTGTATTCAT TTTCTGGATT TATTCCCTAG 2040
AATTTTAAGT 2050
|
